SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-023149
Filing Date
2024-09-10
Accepted
2024-09-10 17:00:15
Documents
1
Period of Report
2024-09-06

Document Format Files

Seq Description Document Type Size
1 form4-09102024_050911.html 4  
1 form4-09102024_050911.xml 4 4245
  Complete submission text file 0001415889-24-023149.txt   5894
Mailing Address FIRST HORIZON PHARMACEUTICAL CORP 660 HEMBREE PKWY STE 106 ROSWELL GA 30076
Business Address
SAXE JON S (Reporting) CIK: 0001114914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 241290694

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)